Taher, A. T. Et Al. 2013. Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study. ANNALS OF HEMATOLOGY , vol.92, no.11 , 1485-1493.

Taher, A. T., Porter, J. B., Viprakasit, V., Kattamis, A., Chuncharunee, S., Sutcharitchan, P., ... Siritanaratkul, N.(2013). Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study. ANNALS OF HEMATOLOGY , vol.92, no.11, 1485-1493.

Taher, Ali Et Al. "Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study," ANNALS OF HEMATOLOGY , vol.92, no.11, 1485-1493, 2013

Taher, Ali T. Et Al. "Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study." ANNALS OF HEMATOLOGY , vol.92, no.11, pp.1485-1493, 2013

Taher, A. T. Et Al. (2013) . "Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study." ANNALS OF HEMATOLOGY , vol.92, no.11, pp.1485-1493.

@article{article, author={Ali T. Taher Et Al. }, title={Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study}, journal={ANNALS OF HEMATOLOGY}, year=2013, pages={1485-1493} }